Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 13Observational 2Expanded_access 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 2229Neoplasms 2031Lung Neoplasms 1094Colorectal Neoplasms 1033Prostatic Neoplasms 892Carcinoma, Non-Small-Cell Lung 751Carcinoma, Hepatocellular 672Stomach Neoplasms 606Pancreatic Neoplasms 599Head and Neck Neoplasms 433Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 346Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Urinary Bladder Neoplasms 289Leukemia, Myeloid, Acute 276Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 251Disease 241Recurrence 225Glioma 217Carcinoma, Renal Cell 207

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Immunoproliferative Disorders × Clear all
NCT04996706 2026-05-26

LEO

Mayo Clinic

Enrolling by invitation
21,000 enrolled
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT05529524 2025-01-24

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

The Lymphoma Academic Research Organisation

Completed
6 enrolled
Lymphoid

Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Follicular, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡